Prognostic significance of pleural fluid data in patients with malignant effusion

Gary-Lee, 2004, Management of malignant pleural effusions, Respirology, 9, 148, 10.1111/j.1440-1843.2004.00566.x Antunes, 2003, BTS guidelines for the management of malignant pleural effusions, Thorax, 58, ii29, 10.1136/thx.58.suppl_2.ii29 Antony, 2001, Management of malignant pleural effusions, Eur Respir J, 18, 402, 10.1183/09031936.01.00225601 Burrows, 2000, Predicting survival in patients with recurrent symptomatic malignant pleural effusions. An assessment of the prognostic values of physiologic, morphologic and quality of life measures of extent of disease, Chest, 117, 73, 10.1378/chest.117.1.73 Good, 1985, The pathogenesis of low glucose, low pH malignant effusions, Am Rev Respir Dis, 131, 737 Foresti, 1990, Malignant pleural effusions: meaning of pleural-fluid pH determination, Oncology, 47, 62, 10.1159/000226786 Martínez-Moragón, 1998, Malignant pleural effusion: prognostic factors for survival and response to chemical pleurodesis in a series of 120 cases, Respiration, 65, 108, 10.1159/000029240 Jiménez, 2005, Etiology and prognostic significance of massive pleural effusions, Respir Med, 99, 1183, 10.1016/j.rmed.2005.02.022 Heffner, 2000, Pleural fluid pH as a predictor of survival for patients with malignant pleural effusion, Chest, 117, 79, 10.1378/chest.117.1.79 Banerjee, 1994, Pleural effusion in breast cancer: a review of the Nottingham experience, Eur J Surg Oncol, 20, 33 Aelony, 2005, Prolonged survival after talc poudrage for malignant pleural mesothelioma: case series, Respirology, 10, 649, 10.1111/j.1440-1843.2005.00763.x Sahn, 1988, Pleural fluid pH in malignant effusions. Diagnostic, prognostic and therapeutic implications, Ann Intern Med, 107, 345, 10.7326/0003-4819-108-3-345 Sánchez-Armengol, 1993, Survival and talc pleurodesis in metastatic pleural carcinoma, revisited. Report of 125 cases, Chest, 104, 1482, 10.1378/chest.104.5.1482 Aelony, 2006, Prognostic value of pleural fluid pH in malignant epithelial mesothelioma after talc poudrage, Respiration, 73, 334, 10.1159/000092085 Crnjac, 2004, Impact of pleural effusion pH on the efficacy of thoracoscopic mechanical pleurodesis in patients with breast carcinoma, Eur J Cardiothorac Surg, 26, 432, 10.1016/j.ejcts.2004.03.010 Bilaçeroglu, 1998, Corynebacterium parvum pleurodesis and survival is not significantly influenced by pleural pH and glucose level, Monaldi Arch Chest Dis, 53, 14 Romero-Romero, 2002, Mesotheliomas have a lower pleural pH and longer survival than metastatic carcinomas, and similar outcome of talc pleurodesis, Am J Respir Crit Care Med, 165, 33S Heffner, 2003, Multilevel and continuous pleural fluid pH likelihood ratios for evaluating malignant pleural effusions, Chest, 123, 1887, 10.1378/chest.123.6.1887 Goldstein, 1997, Is direct collection of pleural fluid into a heparinized syringe important for determination of pleural pH? A brief report, Chest, 112, 707, 10.1378/chest.112.3.707 Yates, 1980, Evaluation of patients with advanced cancer using the Karnofsky performance status, Cancer, 45, 2220, 10.1002/1097-0142(19800415)45:8<2220::AID-CNCR2820450835>3.0.CO;2-Q Al Murri, 2006, Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer, Br J Cancer, 94, 227, 10.1038/sj.bjc.6602922 Forrest, 2005, A prospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancer, Br J Cancer, 92, 1834, 10.1038/sj.bjc.6602591 Deans, 2006, Elevated tumour interleukin-1 beta is associated with systemic inflammation: a marker of reduced survival in gastro-oesophageal cancer, Br J Cancer, 95, 1568, 10.1038/sj.bjc.6603446